| Component | Provisional deliverable |
|---|---|
| Executive judgment | **Partially supported (provisional due to retrieval block).** The seed evidence is consistent with **biallelic SYCE1 loss or damaging variants** causing meiotic failure through synaptonemal-complex dysfunction, but no tool-retrieved full texts or citable contexts were available in this run, so all publication-specific claims require manual verification against the seed papers. Seed PMIDs / PubMed URLs: **25062452** — https://pubmed.ncbi.nlm.nih.gov/25062452/ ; **32402064** — https://pubmed.ncbi.nlm.nih.gov/32402064/ ; **34718620** — https://pubmed.ncbi.nlm.nih.gov/34718620/ ; **35718780** — https://pubmed.ncbi.nlm.nih.gov/35718780/ |
| Key concepts | **SYCE1** is a synaptonemal-complex central element protein in meiotic prophase I. The provisional disease model is: SYCE1 deficiency impairs central element assembly and partner interactions (notably with **SYCP1** and **C14ORF39/SIX6OS1**), causing homologous chromosome synapsis failure, meiotic arrest, and infertility. This mechanistic summary is aligned to the seed hypothesis but remains unverified in this run. |
| Clinical spectrum | **46,XX:** primary ovarian insufficiency / primary amenorrhea reported in a familial setting with a homozygous nonsense variant (seed: PMID 25062452). **46,XY:** non-obstructive azoospermia with **pachytene-stage spermatogenic arrest** reported in patients with SYCE1 CNVs (seed: PMID 35718780). Specific endocrine values, ovarian imaging, follicle depletion data, and detailed biopsy markers could not be confirmed without full text. |
| Variants and inheritance | Provisional inheritance model: **autosomal recessive / biallelic**. Seed evidence mentions **homozygous nonsense c.613C>T**, additional damaging variants affecting protein interactions, and **CNVs within SYCE1**. Exact variant spectrum, zygosity/phasing of CNVs, number of unrelated families, and ACMG classifications require manual verification from the seed articles. |
| Mechanism chain | Provisional chain: **biallelic SYCE1 loss/damaging variant -> reduced/absent SYCE1 -> disrupted interaction with SYCP1 and/or C14ORF39/SIX6OS1 -> synaptonemal-complex central element assembly failure -> homologous chromosome synapsis failure -> pachytene arrest/checkpoint activation -> germ-cell depletion -> 46,XX POI/primary amenorrhea or 46,XY NOA/spermatogenic arrest**. Seed support is distributed across familial human genetics (25062452), model data suggesting loss of protein/transcript and synapsis defects (32402064), interaction/assembly assays (34718620), and human male histology (35718780). |
| Diagnostics / management | Provisional practice implications: include **SYCE1** on infertility/POI/NOA genetic panels with **CNV detection**; in **46,XY**, consider semen analysis, endocrine testing, and testicular biopsy when clinically indicated; in **46,XX**, assess ovarian reserve and POI biochemistry. Management is expected to follow standard care pathways: hormone replacement for POI as indicated, fertility counseling, donor-oocyte discussion for POI, and micro-TESE/ICSI consideration in NOA with cautious expectations if complete meiotic arrest is present. Disorder-specific outcome data were not retrievable here. |
| Ontology labels | **HPO:** Primary ovarian insufficiency; Primary amenorrhea; Female infertility; Azoospermia; Non-obstructive azoospermia; Spermatogenic arrest; Hypergonadotropic hypogonadism. **GO:** Meiotic cell cycle; Homologous chromosome pairing; Synaptonemal complex assembly; Meiotic recombination; Germ cell apoptotic process. **CL:** Primary oocyte; Spermatocyte; Pachytene spermatocyte; Germ cell. **Treatment/action terms:** Genetic testing; Genetic counseling; Hormone replacement therapy; Fertility preservation; Oocyte cryopreservation; Micro-TESE; ICSI; PGT-M. |
| Knowledge gaps | Major gaps are caused by **retrieval block**: no tool-retrieved papers, no citable context IDs, and no figure/table access. Therefore, the following remain unresolved: exact family and cohort counts; full endocrine and histologic data; direct human evidence for checkpoint activation or apoptosis; CNV phasing/zygosity; and any **2023-2024** updates. Several mechanistic links are likely stronger in model or in vitro systems than in directly observed human tissue, but this could not be graded from full text here. |
| Curation leads | Provisional curator leads requiring verification: (1) annotate SYCE1-related gametogenic failure as a **meiotic synaptonemal-complex central element assembly defect**; (2) capture dual-sex phenotype of **46,XX POI/primary amenorrhea** and **46,XY NOA/pachytene arrest**; (3) note support for **loss-of-function and CNV** mechanisms; (4) add partner-interaction mechanism involving **SYCP1** and **C14ORF39/SIX6OS1**. All of these should remain provisional until the seed PMIDs are reviewed directly. |


*Table: This table consolidates the requested report outputs for SYCE1-related gametogenic failure into a single provisional summary. It is useful as a curator-facing checklist because it preserves the seed PMIDs and PubMed URLs while clearly marking all conclusions as limited by the literature retrieval block.*